File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.ddstr.2006.05.001
- Scopus: eid_2-s2.0-33746861983
- Find via
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Article: Overcoming the problem of chronic hepatitis B
Title | Overcoming the problem of chronic hepatitis B |
---|---|
Authors | |
Issue Date | 2006 |
Publisher | Elsevier Ltd, Trends Journals. The Journal's web site is located at http://www.elsevier.com/locate/ddstr |
Citation | Drug Discovery Today: Therapeutic Strategies, 2006, v. 3 n. 2, p. 197-202 How to Cite? |
Abstract | Despite important advances being made in the treatment of chronic hepatitis B (CHB), complete eradication of hepatitis B virus has remained elusive with the current available therapies. Future treatment for CHB is likely to include drugs with more potent antiviral activity targeting different stages of the viral replication cycle and the host response to CHB. Furthermore, combination therapy might prove to be an important aspect in CHB treatment with the availability of newer drugs. © 2006 Elsevier Ltd. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/163009 |
ISSN | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Fung, J | en_US |
dc.contributor.author | Lai, CL | en_US |
dc.contributor.author | Yuen, MF | en_US |
dc.date.accessioned | 2012-09-05T05:26:30Z | - |
dc.date.available | 2012-09-05T05:26:30Z | - |
dc.date.issued | 2006 | en_US |
dc.identifier.citation | Drug Discovery Today: Therapeutic Strategies, 2006, v. 3 n. 2, p. 197-202 | en_US |
dc.identifier.issn | 1740-6773 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/163009 | - |
dc.description.abstract | Despite important advances being made in the treatment of chronic hepatitis B (CHB), complete eradication of hepatitis B virus has remained elusive with the current available therapies. Future treatment for CHB is likely to include drugs with more potent antiviral activity targeting different stages of the viral replication cycle and the host response to CHB. Furthermore, combination therapy might prove to be an important aspect in CHB treatment with the availability of newer drugs. © 2006 Elsevier Ltd. All rights reserved. | en_US |
dc.language | eng | en_US |
dc.publisher | Elsevier Ltd, Trends Journals. The Journal's web site is located at http://www.elsevier.com/locate/ddstr | en_US |
dc.relation.ispartof | Drug Discovery Today: Therapeutic Strategies | en_US |
dc.title | Overcoming the problem of chronic hepatitis B | en_US |
dc.type | Article | en_US |
dc.identifier.email | Fung, J:jfung@sicklehut.com | en_US |
dc.identifier.email | Lai, CL:hrmelcl@hku.hk | en_US |
dc.identifier.email | Yuen, MF:mfyuen@hkucc.hku.hk | en_US |
dc.identifier.authority | Fung, J=rp00518 | en_US |
dc.identifier.authority | Lai, CL=rp00314 | en_US |
dc.identifier.authority | Yuen, MF=rp00479 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/j.ddstr.2006.05.001 | en_US |
dc.identifier.scopus | eid_2-s2.0-33746861983 | en_US |
dc.identifier.hkuros | 130672 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-33746861983&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 3 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.spage | 197 | en_US |
dc.identifier.epage | 202 | en_US |
dc.publisher.place | United Kingdom | en_US |
dc.identifier.scopusauthorid | Fung, J=23091109300 | en_US |
dc.identifier.scopusauthorid | Lai, CL=7403086396 | en_US |
dc.identifier.scopusauthorid | Yuen, MF=7102031955 | en_US |
dc.identifier.issnl | 1740-6773 | - |